Promising ‘first’ in Alzheimer’s drug development
Date:
A new breakthrough in the development of drugs to treat Alzheimer’s Disease is looking very promising according to researchers.
Current treatments do not work on both major aggregation-promoting ‘hotspots’ of the Tau protein (a key driver in neurodegeneration). This drug addresses this critical gap in current treatments as it works on both.
In studies on fruit flies, the drug, a peptide inhibitor called RI-AG03, was effective at preventing the build-up of Tau proteins.
Read the full article here.
